Arrhythmogenic Hearts in PKD2 Mutant Mice Are Characterized by Cardiac Fibrosis, Systolic, and Diastolic Dysfunctions
Open Access
- 26 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Abstract
Autosomal dominant polycystic kidney disease (PKD) is a hereditary disorder affecting multiple organs, including the heart. PKD has been associated with many cardiac abnormalities including the arrhythmogenic remodeling in clinical evaluations. In our current study, we hypothesized that Pkd2 gene mutation results in structural and functional defects in the myocardium. The structural and functional changes of Pkd2 mutant hearts were analyzed in the myocardial-specific Pkd2 knockout (KO) mouse. We further assessed a potential role of TGF-b1 signaling in the pathology of Pkd2-KO hearts. Hearts from age-matched 6-month-old MyH6•Pkd2wt/wt (control or wild-type) and MyH6•Pkd2flox/flox (mutant or Pkd2-KO) mice were used to study differential heart structure and function. Cardiac histology was used to study structure, and the “isolated working heart” system was adapted to mount and perfuse mouse heart to measure different cardiac parameters. We found that macrophage1 (M1) and macrophage 2 (M2) infiltration, transforming growth factor (TGF-b1) and TGF-b1 receptor expressions were significantly higher in Pkd2-KO, compared to wild-type hearts. The increase in the extracellular matrix in Pkd2-KO myocardium led to cardiac hypertrophy, interstitial and conduction system fibrosis, causing cardiac dysfunction with a predisposition to arrhythmia. Left ventricular (LV) expansion or compliance and LV filling were impaired in fibrotic Pkd2-KO hearts, resulted in diastolic dysfunction. LV systolic contractility and elastance decreased in fibrotic Pkd2-KO hearts, resulted in systolic dysfunction. Compared to wild-type hearts, Pkd2-KO hearts were less responsive to the pharmacological stress-test and changes in preload. In conclusion, Pkd2-KO mice had systolic and diastolic dysfunction with arrhythmogenic hearts.Keywords
This publication has 50 references indexed in Scilit:
- Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF β/Smad Activation and Cardiac Fibrosis Induced by Angiotensin IIPLOS ONE, 2012
- Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker ImplantJournal of Cardiovascular Electrophysiology, 2011
- Identification of low circulatory transforming growth factor β-1 in patients with degenerative heart valve disease☆Interactive CardioVascular and Thoracic Surgery, 2010
- Hypertension in Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Renal Volume, Renin-Angiotensin-Aldosterone System, Hypertension, and Left Ventricular Hypertrophy in Patients with Autosomal Dominant Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2009
- Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2Proceedings of the National Academy of Sciences, 2007
- THE PRESSURE-VOLUME LOOP REVISITEDShock, 2006
- Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney diseaseKidney International, 1992